Harry A. Korman joined the Viatris board of directors after two years of service on the Mylan board, where he most recently chaired the Risk Oversight Committee and was a member of the Compliance, Governance & Nominating, and Science and Technology Committees. Korman previously served as Mylan’s global chief operating officer, president of Mylan North America and president of Mylan Pharmaceuticals Inc. He joined Mylan in 1996 after the company’s acquisition of UDL Laboratories, Inc., now known as Mylan Institutional Inc., where he served as its president. Korman also previously served as a director and vice chairman of the Generic Pharmaceutical Association, now known as the Association for Accessible Medicines, and was a director and vice chairman of the HDMA Foundation, which provides research and education focused on healthcare supply issues.
Personal Details
Title: Mr
Surname: Korman
M/F: Male
Nationality: American
Country of Birth: American
Language: English
Qualification: Not available
Industry:
Qualifications & Experience
Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
Company
Committee
Role
Appointment Date
Resignation Date
Viatris
Other (specify)
Member
Viatris
Risk & Compliance
Member
Independence Questions
Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.